Prelude Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Prelude Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$217K	–	2155
2021 Q1	$217K	Buy	+1,000	New	+$188K	0.01%	1296
2019 Q2	–	Sell	-600	Closed	-$101K	–	2310
2019 Q1	$101K	Buy	+600	New	+$89.3K	0.01%	930

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Prelude Capital Management's GWPH Position: Q2 2021 in Review

Prelude Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 18,653 shares — an estimated $4.05M sold.

Prelude Capital Management first reported a position in GWPH in Q3 2013 and held it in 12 quarters. The position peaked at $4.05M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Prelude Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Prelude Capital Management sold 18,653 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.05M.
Prelude Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2013 and held it in 12 quarters.
Prelude Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.05M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.